TotalEnergies joins FDJ UNITED as women's cycling team co-title sponsor for five seasonsPUBT·Nov 16, 2026 at 05:14 PMTTE-0.73%
AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nodsFiercepharma·Nov 16, 2026 at 03:43 PMAZN+0.04%AZN
How Long Term LNG Supply Deals Will Impact TotalEnergies (ENXTPA:TTE) InvestorsSimplywall·Nov 16, 2026 at 01:15 PMTTE-0.73%
AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europebenzinga_article·Nov 16, 2026 at 12:52 PMAZN+0.04%AZNCF
China Adds Record 51 Innovative Drugs to Public Medical Insurance CatalogYicai·Nov 16, 2026 at 11:44 AMAZN+0.04%NVO-0.10%
Sofinnova Partners backs European life sciences sector with €725M raisePharmaceutical Technology·Nov 16, 2026 at 09:53 AMABVX-3.97%AHKSY-2.01%
AstraZeneca secures FDA approval for Imfinzi combo in MIBCPharmaceutical Technology·Nov 16, 2026 at 09:37 AMAZN+0.04%AZN
AstraZeneca: Alexion's Klygefa Gets EU Approval To Treat Adults With Generalised Myasthenia Gravisrttnews·Nov 16, 2026 at 07:45 AMAZN+0.04%AZN
REG - AstraZeneca PLC - Baxfendy recommended for approval in the EULondon Stock Exchange·Nov 16, 2026 at 07:15 AMAZN+0.04%AZN
Weekly Recap | AstraZeneca -1.06%, most brokers rate it buyWeekly Review·Nov 14, 2026 at 06:02 AMAZN+0.04%
Is AstraZeneca (LSE:AZN) Still Cheap After Its 83% Five Year Run?Simplywall·Nov 14, 2026 at 01:07 AMAZN+0.04%AZN
AstraZeneca rises 4% in after-hours on positive EU opinion for BaxfendyMarket Movers·Nov 13, 2026 at 11:41 PMAZN+0.04%
AstraZeneca (AZN) Wins FDA Approval for IMFINZI Bladder Cancer RegimenTradingView·Nov 13, 2026 at 11:39 PMAZN+0.04%AZN